Key result
Cardiac implantable electronic device infections occur in 1-3% of cases and carry 1-year mortality rates as high as 25%, highlighting the need for prophylactic measures and early management.
Answers are grounded in this paper and cite their sources.
This editorial highlights recent articles on the implementation of extended realities in cardiovascular medicine and the management of cardiac implantable electronic device infections.
Merging virtual and physical experiences: extended realities in cardiovascular medicine' by Tsung-Ying Tsai from the Taichung Veterans General Hospital in Taiwan, and colleagues. 1 The authors note that technological advancement and the COVID-19 pandemic have brought virtual learning and working into our daily lives.Extended realities (XR), an umbrella term for all the immersive technologies that merge virtual and physical experiences, will undoubtedly be an indispensable part of future clinical practice.The intuitive and three-dimensional nature of XR has great potential to benefit healthcare providers and empower patients and physicians.In the past decade, the implementation of XR into cardiovascular medicine has flourished such that it is now integrated into medical training, patient education, pre-procedural planning, intra-procedural visualization, and post-procedural care.This review article discusses how XR could provide innovative care and complement traditional practice, as well as addressing its limitations and considering its future perspectives.The Issue continues with a Focus on arrhythmias.In a Viewpoint article entitled 'Cardiac device infection: removing barriers to timely and adequate treatment', Dan Atar from the Oslo University Hospital Ullevaal in Oslo, Norway, and colleagues note that infection related to cardiac implantable electronic devices (CIEDs) occurs in ∼1%-3% of cases during the lifetime of the device. 2These include pocket infection, systemic infection, and infective endocarditis, and-although uncommon-they have a considerable impact, including hospitalization, 1-year mortality rates as high as 25%, and increased healthcare costs.The incidence of CIED infection has been rising over the past 20 years, underscoring the need for both prophylactic measures and early diagnosis and management of suspected infections.Prevention of device infection should focus on the actionable risk factors outlined in the European Heart Rhythm Association (EHRA) guidance summary.Higher risks of pocket CIED infections have been associated with CIED reoperations, young age, and a more complex type of CIED, whereas systemic infections have been associated with
No takes yet. Share an insight, caveat, or question.
Filippo Crea (2023) conducted an editorial in Cardiovascular medicine and cardiac device infection. Extended realities (XR) and CIED infection management was evaluated. Cardiac implantable electronic device infections occur in 1-3% of cases and carry 1-year mortality rates as high as 25%, highlighting the need for prophylactic measures and early management.
Synapse has enriched 10 related papers. Consider them for comparative context: